Interstitial pneumonitis in acute leukemia patients submitted to T- depleted matched and mismatched bone marrow transplantation

International Journal of Radiation Oncology Biology Physics

Volumn 41, Issue 3, 1998, Pages 651-657

  Aristei, Cynthia ^a   Aversa, Franco ^a   Chionne, Fausto ^a   Martelli, Massimo F ^a   Latini, Paolo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Acute leukemia; Interstitial pneumonitis; Matched BMT; Mismatched BMT; T depleted BMT

Indexed keywords

CYCLOPHOSPHAMIDE; THIOTEPA; THYMOCYTE ANTIBODY;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; HUMAN; INTERSTITIAL PNEUMONIA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT PLANNING; WHOLE BODY RADIATION;

ACUTE DISEASE; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BONE MARROW TRANSPLANTATION; CHILD; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GRAFT VS HOST DISEASE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PNEUMONIA, VIRAL; T-LYMPHOCYTES; TRANSPLANTATION CONDITIONING;

EID: 0031776992     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00068-6     Document Type: Article

References (49)

1. Cosset J.M., Socie G., Dubray B., Girinsky T., Fourquet A., Gluckman E. Single dose versus fractionated total body irradiation before bone marrow transplantation radiobiological and clinical considerations . Int. J. Radiat. Oncol. Biol. Phys. 30:1994;477-492.
2. Shank B. The balancing act pneumonitis vs relapse in cytoreductive regimens containing total body irradiation . Int. J. Radiat. Oncol. Biol. Phys. 36:1996;261-262.
3. Weiner R.S., Bortin M.M., Gale R.P., Gluckman E., Kay H.E.M., Kolb H.J., Hartz A.J., Rimm A.A. Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. Ann. Intern. Med. 104:1986;168-175.
4. Reisner Y., Friedrich W., Fabian I. A shorter procedure for preparation of E-rosette-depleted bone marrow for transplantation. Transplantation. 42:1986;312-316.
5. Aristei C., Aversa F., Raymondi C., Marsella A.R., Panizza B.M., Perrucci E., Piro F., Maranzano E., Lupattelli M., Martelli M.F., Latini P. Allogeneic matched T-cell-depleted bone-marrow transplantation for acute leukemia patients. Cancer J. Sci. Am. 2:1996;330-334.
6. Aversa F., Tabilio A., Terenzi A., Velardi A., Falzetti F., Giannoni C., Iacucci R., Zei T., Martelli M.P., Gambelunghe C., Rossetti M., Caputo P., Latini P., Aristei C., Raymondi C., Reisner Y., Martelli M.F. Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood. 84:1994;3948-3955.
7. Reisner Y., Martelli M.F. Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells. Immunol. Today. 16:1995;437-440.
8. Aristei, C.; Aversa, F.; Panizza, B. M.; Perrucci, E.; Barone, V.; Marafioti, L.; Raymondi, C.; Terenzi, A.; Martelli, M. F.; Latini, P. T-cell depleted haploidentical three loci mismatched bone-marrow and peripheral blood stem cell transplantation in acute leukaemia patients. Int. J. Radiat. Oncol. Biol. Phys. 36(Suppl. 1); 1996 (abstr).
9. Anasetti C., Amos D., Beatty P.G., Appelbaum F.R., Besinger W., Buckner C.D., Clift R., Doney C., Martin P.J., Mickelson E., Nisperos B., O'Quigley J., Ramberg R., Sanders J.E., Stewart P., Storb R., Sullivan K.M., Witherspoon R.P., Thomas E.D., Hansen J.A. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N. Engl. J. Med. 320:1989;197-204.
10. Patterson J., Prentice H.G., Brenner M.K., Gilmore M., Janossy G., Ivory K., Skeggs D., Morgan H., Lord J., Blacklock H.A., Hoffbrand A.V., Apperley J.F., Goldman J.M., Burnett A., Gribben J., Alcorn M., Pearson C., McVickers I., Hann I.M., Reid C., Wardle D., Gravett P.J., Bacigalupo A., Robertson A.G. Graft rejection following HLA matched T-lymphocyte depleted bone marrow transplantation. Br. J. Haematol. 63:1986;221-230.
11. Salomon O., Lapidot T., Terenzi A., Lubin I., Rabi I., Reisner Y. Induction of donor-type chimerism in murine recipients of bone marrow allografts by different radiation regimens currently used in treatment of leukemia patients. Blood. 76:1990;1872-1878.
12. Storb R., Raff R.F., Appelbaum F.R., Graham T.C., Schuening F.G., Sale G., Pepe M. Comparisons of fractionated to single-dose total body irradiation in conditioning canine littermates for DLA-identical marrow grafts. Blood. 74:1989;1139-1143.
13. Storb R., Raff R.F., Appelbaum F.R., Deeg H.J., Graham T.C., Schuening F.G., Sale G., Bryant E., Seidel K. Fractionated versus single-dose total body irradiation at low and high dose rates to condition canine littermates for DLA-identical marrow grafts. Blood. 83:1994;3384-3389.
14. Young J.W., Papadopoulos E.B., Cunningham I., Castro-Malaspina H., Flomenberg N., Carabasi M.H., Gulati S.C., Brochstein J.A., Heller G., Black P., Collins N.H., Shank B., Kernan N.A., O'Reilly R.J. T-cell-depleted allogeneic bone marrow transplantation in adults with acute nonlymphocytic leukemia in first remission. Blood. 79:1992;3380-3387.
15. Safwat A., Bentzen S.M., Nielsen O.S., Mahmoud H.K., Overgaard J. Repair capacity of mouse lung after total body irradiation alone or combined with cyclophosphamide. Radiother. Oncol. 40:1996;249-257.
16. Yan R., Peters J.J., Travis E. Cyclophosphamide 24 hours before or after total body irradiation effects on lung and bone marrow . Radiother. Oncol. 21:1991;149-156.
17. Blume K.G., Forman S.J., Snyder D.S., Nademanee A.P., O'Donnell M.R., Fahey J.L., Krance R.A., Sniecinski I.J., Stock A.D., Findley D.O., Lipsett J.A., Schmidt G.M., Nathwani M.B., Hill L.R., Metter G.E. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remission. Transplantation. 43:1987;389-392.
18. Cosset J.M., Baume D., Pico J.L., Shank B., Girinski T., Benhamou E., Briot E., Malaise E., Hayat M., Dutreix J. Single dose versus hyperfractionated total body irradiation before allogeneic bone marrow transplantation A non-randomized comparative study of 54 patients at the Institut Gustave Roussy . Radiother. Oncol. 15:1989;151-160.
19. Inoue T., Masaoka T., Shibata H. Interstitial pneumonitis following allogeneic bone marrow transplantation in the treatment of leukemia based on BMT survey in Japan. Strahlenther. Onkol. 164:1988;729-733.
20. Latini P., Aristei C., Aversa F., Checcaglini F., Maranzano E., Panizza B.M., Perrucci E., Carotti A., Martelli M.F. Interstitial pneumonitis after hyperfractionated total body irradiation in HLA-matched T-depleted bone marrow transplantation. Int. J. Radiat. Oncol. Biol. Phys. 23:1992;401-405.
21. Shank B., Chu F.C.H., Dinsmore R., Kapoor N., Kirkpatrick D., Teitelbaum H., Reid A., Bonfiglio P., Simpson L., O'Reilly R. Hyperfractionated total body irradiation for bone marrow transplantation Results in seventy leukemia patients with allogeneic transplants . Int. J. Radiat. Oncol. Biol. Phys. 9:1983;1607-1611.
22. Shank B., O'Reilly R.J., Cunningham I., Kernan N., Yaholom J., Brochstein J., Castro-Malaspina H., Kutcher G.J., Mohan R., Bonfiglio P. Total body irradiation for bone-marrow transplantation The Memorial Sloan-Kettering Cancer Center experience . Radiother. Oncol. Suppl. 1:1990;68-81.
23. Socie G., Devergie A., Girinsky T., Reiffers J., Vernant J.P., Le Bourgeois J.P., Herve P., Guyotat D., Maraninchi D., Rio B., Michallet M., Jouet J.P., Milpied N., Leblond V., Pico J., Attal M., Belanger C., Gluckman E., Cosset J.M. Influence of the fractionation of total body irradiation on complications and relapse rate for chronic myelogenous leukemia. Int. J. Radiat. Oncol. Biol. Phys. 20:1991;397-404.
24. Thomas E.D., Clift R.A., Hersman J., Sanders J.E., Stewart P., Buckner C.D., Fefer A., McGuffin R., Smith J.W., Storb R. Marrow transplantation for acute nonlymphoblastic leukemia in first remission using fractionated or single-dose irradiation. Int. J. Radiat. Oncol. Biol. Phys. 8:1982;817-821.
25. Kim T.H., McGlave P.B., Ramsay N., Woods W., Bostrom B., Vercellotti G., Hurd D., Krivit W., Nesbit M., Haake R., Khan F., Kersey J.H. Comparison of two total body irradiation regimens in allogeneic bone marrow transplantation for acute non-lymphoblastic leukemia in first remission. Int. J. Radiat. Oncol. Biol. Phys. 19:1990;889-897.
26. Ozsahin M., Pène F., Touboul E., Gindrey-Vie B., Dominique C., Lefkopoulos D., Krzisch C., Balosso J., Vitu L., Schwartz L.H., Rio B., Gorin N.C., Leblond V., Schlienger M., Laugier A. Total body irradiation before bone marrow transplantation. Results of two randomized instantaneous dose rates in 157 patients. Cancer. 69:1992;2853-2865.
27. Barrett A., Depledge M.H., Powles R.L. Interstitial pneumonitis following bone marrow transplantation after low dose rate total body irradiation. Int. J. Radiat. Oncol. Biol. Phys. 9:1983;1029-1033.
28. Fyles G.M., Messner H.A., Lockwood G., Curtis J.E., Rider W., Minden M.D., Meharchand J.M., Lipton J., Tritchler D., Van Dyk J., Keane T., Sutcliffe S. Long-term results of bone marrow transplantation for patients AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rate. Bone Marrow Transplant. 8:1991;453-463.
29. Girinsky T., Socie G., Ammarguellat H., Cosset J.M., Briot E., Bridier A., Gluckman E. Consequences of two different doses to the lungs during a single dose of total body irradiation Results of a randomized study on 85 patients . Int. J. Radiat. Oncol. Biol. Phys. 30:1994;821-824.
30. Morgan T.L., Falk P.M., Kogut N., Shah K.H., Tome M., Kagan A.R. A comparison of single-dose and fractionated total body irradiation on the development of pneumonitis following bone marrow transplantation. Int. J. Radiat. Oncol. Biol. Phys. 36:1996;61-66.
31. Latini P., Aristei C., Aversa F., Checcaglini F., Maranzano E., Raymondi C., Panizza B.M., Perrucci E., Martelli M.F. Lung damage following bone marrow transplantation after hyperfractionated total body irradiation. Radiother. Oncol. 22:1991;127-132.
32. Beatty P.G., Clift R.A., Mickelson E.M., Nisperos B.B., Flournoy N., Martin P.J., Sanders J.E., Stewart P., Buckner C.D., Storb R., Thomas E.D., Hansen J.A. Marrow transplantation from related donors other than HLA-identical siblings. N. Engl. J. Med. 313:1985;765-771.
33. Filipovich A.H., Ramsay N.K.C., Arthur D.C., McGlave P., Kim T., Kersey J.H. Allogeneic bone marrow transplantation with related donors other than HLA MLC-matched siblings, and the use of antithymocyte globulin, prednisone, and methotrexate for prophylaxis of graft-versus-host disease. Transplantation. 39:1985;282-285.
34. Henslee-Downey P.J. Mismatched bone marrow transplantation. Curr. Opin. Oncol. 7:1995;115-121.
35. Henslee-Downey P.J., Abhyankar S.H., Parrish R.S., Pati A.R., Godder K.T., Neglia W.J., Goon-Johnson K.S., Geier S.S., Lee C.G., Gee A.P. Use of partially mismatched related donors extends access to allogeneic marrow transplant. Blood. 89:1997;3864-3872.
36. Hows J.M., Yin J.L., Marsh J., Swirsky D., Jones L., Apperley J.F., James D.C.O., Smithers S., Batchelor J.R., Goldman J.M., Gordon-Smith E.C. Histocompatible unrelated volunteer donors compared with HLA non-identical family donors in marrow transplantation for aplastic anemia and leukemia. Blood. 68:1986;1322-1328.
37. Powles R.L., Morgenstern G.R., Kay H.E.M., McElwain T.J., Clink H.M., Dady P.J., Barrett A., Jameson B., Depledge M.H., Watson J.G., Sloane J., Leigh M., Lumley H., Hedley D., Lawler S.D., Filshie J. Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia. Lancet. 8:1983;612-615.
38. Szydlo R., Goldman J.M., Klein J.P., Gale R.P., Ash R.C., Bach F.H., Bradley B.A., Casper J.T., Flomenberg N., Gajewsky J.L., Gluckman E., Henslee-Downey P.J., Hows J.M., Jacobsen N., Kolb H.J., Lowenberg B., Masaoka T., Rowlings P.A., Sondel P.M., van Bekkum D.W., van Rood J.J., Vowels M.R., Zhang M.J., Horowitz M.M. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J. Clin. Oncol. 15:1997;1767-1777.
39. Reusser P., Attenhofer R., Hebart H., Helg C., Chapuis B., Einsele H. Cytomegalovirus-specific T-cell immunity in recipients of autologous peripheral blood stem cells or bone marrow transplants. Blood. 89:1997;3873-3879.
40. Bishop M.R., Henslee-Downey P.J., Anderson J.R., Romond E.H., Marciniak E., Yankey R., Reeves M., Thompson J.S. Long-term survival in advanced chronic myelogenous leukemia following bone marrow transplantation from haploidentical related donors. Bone Marrow Transplant. 18:1996;747-753.
41. Cahn J.Y., Herve P., Flesch M., Plouvier E., Racadot E., Vuillier J., Montcuquet P., Noir A., Rozenbaum A., Leconte des Floris R. Marrow transplantation from HLA non-identical family donors for the treatment of leukaemia A pilot study of 15 patients using additional immunosuppression and T-cell depletion . Br. J. Haematol. 69:1988;345-349.
42. Fleming D.R., Henslee-Downey P.J., Romond E.H., Harder E.J., Marciniak E., Munn R.K., Messino M.J., Macdonald J.S., Bishop M., Rayens M.K., Thompson J.S., Foon K.A. Allogeneic bone marrow transplantation with T cell-depleted partially matched related donors for advanced acute lymphoblastic leukemia in children and adults A comparative matched cohort study . Bone Marrow Transplant. 17:1996;917-922.
43. Trigg M.E., Billing R., Sondel P.M., Exten R., Hong R., Bozdech M.J., Horowitz S.D., Finlay J.L., Moen R., Longo W., Erickson C., Peterson A. Clinical trial depleting T lymphocytes from donor marrow for matched and mismatched allogeneic bone marrow transplants. Cancer Treat. Rep. 69:1985;377-386.
44. Vowels M.R., Lam Po Tang R., Mameghan H., Honeyman M., Russel S. Bone marrow transplantation in children using closely matched related and unrelated donors. Bone Marrow Transplant. 8:1991;87-92.
45. Granena A., Carreras E., Rozman C., Salgado C., Sierra J., Algara M., Rovira M., Valls A. Interstitial pneumonitis after BMT 15 years experience in a single institution . Bone Marrow Transplant. 11:1993;453-458.
46. Sutton L., Kuentz M., Cordonnier C., Blaise D., Devergie A., Guyotat D., Leblond V., Flesch M., Bordigoni P., Attal M., Reiffers J., Ifrah N., Milpied N., Gratecos N., Caillot D., Troussard X., Belanger C., Facon T., Pico J.L., Michallet M., Rio B., Lioure B., Vernant J.P. Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia in first complete remission factors predictive of transplant-related mortality and influence of total body irradiation modalities . Bone Marrow Transplant. 12:1993;583-589.
47. + T cells expressing NK receptors for major histocompatibility complex class I after "three loci" HLA-incompatible bone marrow transplantation. Blood. 87:1995;3993-4000.
48. Reisner Y., Lapidot T., Singer T.S., Schwartz E. The host barrier in animal models of T-cell depleted allogeneic bone marrow transplantation. Martelli M.F., Grignani F., Reisner Y. T-cell depletion in allogeneic bone marrow transplantation. 1988;37-48 Serono Symposia Review No. 13, Rome.
49. Terenzi A., Aristei C., Aversa F., Perruccio K., Chionne F., Raymondi C., Latini P., Martelli M.F. Efficacy of fludarabine as an immunosuppressor for bone marrow transplantation conditioning Preliminary results . Transplant. Proc. 28:1996;3101.